Coiante Scott M — SEC Form 4 filings

SEC reporting owner CIK 1608536. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-08-26 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LEXICON PHARMACEUTICALS, INC. (LXRX)SVP, Chief Financial Officer48
AGILE THERAPEUTICS INC (AGRX)Chief Financial Officer12

Form 4 filings — Coiante Scott M

FiledFormIssuerReported transactionsSource
2026-03-034LEXICON PHARMACEUTICALS, INC. (LXRX)Option exercise (M): 160,237 · Tax withholding (F): 54,881 @ $1.47 · Option exercise (M): 160,237 (derivative)EDGAR
2026-02-174LEXICON PHARMACEUTICALS, INC. (LXRX)Grant/award (A): 272,680 (derivative) @ $0 · Grant/award (A): 409,020 (derivative) @ $0EDGAR
2025-02-184LEXICON PHARMACEUTICALS, INC. (LXRX)Grant/award (A): 721,070 (derivative) @ $0 · Grant/award (A): 480,710 (derivative) @ $0EDGAR
2025-01-024LEXICON PHARMACEUTICALS, INC. (LXRX)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2024-08-264AGILE THERAPEUTICS INC (AGRX)Disposition to issuer (D): 15,000 @ $1.52 · Disposition to issuer (D): 5,080 @ $1.52EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1608536 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →